Paradigm Asset Management CO LLC Abbott Laboratories Transaction History

Paradigm Asset Management CO LLC

$265 Million
Q2 2025

A detailed history of Paradigm Asset Management CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 8,500 shares of ABT stock, worth $1.14 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

8,500

Previous 9,000 5.56%

Holding current value

$1.14 Million

Previous $1.19 Million 3.1%

% of portfolio

0.44%

Previous 0.48%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$123.95 - $138.08 $61,975 - $69,040	-500 Reduced 5.56%	8,500 $1.16 Million
Q4 2024 Feb 03, 2025	SELL	$111.93 - $119.39 $279,825 - $298,475	-2,500 Reduced 21.74%	9,000 $1.02 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $1.02 Million - $1.14 Million	10,100 Added 721.43%	11,500 $1.19 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $43,808 - $48,384	-400 Reduced 22.22%	1,400 $159,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $886,864 - $988,152	-8,800 Reduced 83.02%	1,800 $196,000
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $304,192 - $356,864	3,200 Added 43.24%	10,600 $1.16 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $48,380 - $56,015	-500 Reduced 6.33%	7,400 $716 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $255,174 - $308,425	2,500 Added 46.3%	7,900 $858,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $34,998 - $38,718	-300 Reduced 5.26%	5,400 $637,000
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 3.39%	5,700 $683,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.11 Million - $1.21 Million	-10,600 Reduced 64.24%	5,900 $645,000
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $247,428 - $300,483	-2,700 Reduced 14.06%	16,500 $1.8 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $264,166 - $338,100	-3,450 Reduced 15.23%	19,200 $1.76 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $86,361 - $96,140	1,100 Added 5.1%	22,650 $1.97 Million
Q3 2019 Nov 15, 2019	SELL	$81.84 - $88.74 $392,832 - $425,952	-4,800 Reduced 18.22%	21,550 $1.8 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $761,596 - $888,250	10,450 Added 65.72%	26,350 $0
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $59,598 - $72,054	-900 Reduced 5.36%	15,900 $0
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $1.1 Million - $1.25 Million	16,800 New	16,800 $1.22 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.

Account

Paradigm Asset Management CO LLC Abbott Laboratories Transaction History